CDC: Number of U.S. Counties With Zika-Carrying Mosquitoes Up

Share this content:
CDC: Number of U.S. Counties With Zika-Carrying Mosquitoes Up
CDC: Number of U.S. Counties With Zika-Carrying Mosquitoes Up

WEDNESDAY, June 21, 2017 (HealthDay News) -- Mosquitoes that can spread Zika, dengue, and chikungunya viruses are in more counties in the southern United States than previously thought, according to a study published online June 19 in the Journal of Medical Entomology.

The U.S. Centers for Disease Control and Prevention conducted a mosquito survey in spring 2016. At the end of last year, the research team conducted a follow-up survey of mosquito control agencies, university researchers, and state and local health departments. That survey included Zika-bearing mosquito information from 38 new counties. The total body of evidence now runs from 1995 to 2016.

The findings revealed a 21 percent increase in the number of counties with Zika-carrying mosquitoes (Aedes aegypti). There was also a 10 percent increase in counties with dengue-spreading mosquitoes (Aedes albopictus).

Since 1995, the Zika-bearing mosquito has been documented in all states in the southern United States, with the most widespread county-level distributions in southern California, Arizona, Texas, Louisiana, and Florida. Additional counties with evidence of dengue-spreading mosquitoes are primarily in Kansas, Texas, Mississippi, Arkansas, and North Carolina, according to the report. Meanwhile, counties with both types of mosquito were located mostly in southern California, Arizona, Texas, Florida, and Maryland.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Even Overdose Doesn't Stop Opioid Prescribing

Even Overdose Doesn't Stop Opioid Prescribing

Few receive medication-assisted treatment after hospital discharge, researchers find

NT-ProBNP-Guided Treatment No Benefit in High-Risk HFrEF

NT-ProBNP-Guided Treatment No Benefit in High-Risk HFrEF

No improvement in clinical outcomes versus usual care in heart failure and reduced ejection fraction

Oral Corticosteroids No Benefit for LRI in Non-Asthmatic Adults

Oral Corticosteroids No Benefit for LRI in Non-Asthmatic ...

No decrease in cough duration, severity for adults without asthma with lower respiratory tract symptom

is free, fast, and customized just for you!

Already a member?

Sign In Now »